TI-YON WARD: Open Payments
NPI 1841628047 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 7 companies in 2025. Trend: 2023 $228 · 2024 $103 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
Products named: REXULTI, CAPLYTA, COBENFY, AUSTEDO XR, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
